Research Article
Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder
Table 4
The distribution of Toxoplasma gondii and Toxocara antibodies in patients with schizophrenia based on clinical course of treatment.
| | Clinical course | (%) | value | OR | CI95 |
| Toxoplasma gondii | First episode | 13/30 (43.33%) | 0.1 | 2.08 | 0.84–5.12 | Recurrent episodes | 18/67 (26.86%) | Toxocara | First episode | 8/30 (26.66%) | 0.06 | 0.22 | 0.06–0.75 | Recurrent episodes | 5/30 (16.66%) |
|
|